Discover ANY AI to make more online for less.

select between over 22,900 AI Tool and 17,900 AI News Posts.


qz
Eli Lilly is acquiring blood cancer drug developer Ajax Therapeutics for up to $2.3 billion

The deal centers on AJ1-11095, a first-in-class experimental oral drug in early-stage trials for myelofibrosis patients

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine
Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

<p><img width="1536" height="1024" src="https://the-decoder.com/wp-content/uploads/2025/09/medical_ai_illustration-2.png" class="attachment-full size-full w [...]

Match Score: 113.38

FDA approves at-home pap smear alternative device for cervical cancer screening
FDA approves at-home pap smear alternative device for cervical cancer scree

<p>The Food and Drug Administration has <a data-i13n="cpos:1;pos:1" href="https://www.getteal.com/news/fda-approves-teal-healths-teal-wand-tm---the-first-and-only-at-home-self- [...]

Match Score: 95.88

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/ff0c1c3c426ad52686faeda3e7ef0e44.jpg"/><p>Eli Lilly’s (<a class="sc- [...]

Match Score: 94.46

qz
Eli Lilly is buying cancer biotech Kelonia Therapeutics for more than $2 bi

The deal expands Lilly's in vivo CAR-T cancer therapy pipeline, anchored by a multiple myeloma drug that showed early clinical results [...]

Match Score: 80.38

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/c45b4d7b37b7f8cb4e6dd83e52b76b28.jpg"/><p>An Eli Lilly exec said the company†[...]

Match Score: 75.57

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s
Eli Lilly's online health platform just expanded beyond weight loss to

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e4b70d65bbdfcb4854862d2a597ad777.jpg"/><p>Just about a year after launching a [...]

Match Score: 75.57

qz
Eli Lilly looks beyond GLP-1s with a $3 billion cancer buy

Eli Lilly announced it will acquire Kelonia Therapeutics for $3.25 billion upfront to expand its oncology and genetic medicines pipeline [...]

Match Score: 70.75

Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval
Eli Lilly's Alzheimer's drug is rejected by EU regulators over br

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/fb66dd93d1df3e62d60ac598040d5952.jpg"/><p>The European Union’s health regula [...]

Match Score: 69.90

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss dru

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/746af559340fe82bc9f6bf71316594d7.jpg"/><p>Novo Nordisk (<a class="sc-1 [...]

Match Score: 65.63